Organicell Regenerative Medicine, Inc.

OCELOTCHealthcare

$2.74

$-0.01(-0.27%)

Market Cap$19974944

P/E Ratio—

52W High$4.8

52W Low$0.896

Avg Volume2K

Open$2.65

Beta1.36

Overview

Organicell Regenerative Medicine, Inc. (OCEL) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

OCEL · earnings · updated Jun 8, 2026

Latest Earnings

Q3 FY2023Report Date: Jul 31, 2023

EPS Actual

-$0.00

Revenue

$0.00B

Fiscal Period

Q3 FY2023

FY ends December

Report Date

Jul 31, 2023

After Market Close

OCEL reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2023	Jul 31, 2023	—	-$0.00	—	$0.00B	—	—
— Q2 FY2023	Apr 30, 2023	—	-$0.00	—	$0.00B	—	—
— Q1 FY2023	Jan 31, 2023	—	-$0.00	—	$0.00B	—	—

Q3 FY2023

Jul 31, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

Apr 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2023

Jan 31, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High
Q4 FY2024	$1.54	$1.54	$1.54
Q3 FY2024	$1.34	$1.34	$1.34
Q2 FY2024	$1.57	$1.57	$1.57
Q1 FY2024	$2.09	$2.09	$2.09
Q4 FY2023	$1.39	$1.39	$1.39
Q3 FY2023	$1.19	$1.19	$1.19

Revenue Estimates

Period	Low	Consensus	High
Q4 FY2024	$0.0B	$0.0B	$0.0B
Q3 FY2024	$0.0B	$0.0B	$0.0B
Q2 FY2024	$0.0B	$0.0B	$0.0B
Q1 FY2024	$0.0B	$0.0B	$0.0B
Q4 FY2023	$0.0B	$0.0B	$0.0B
Q3 FY2023	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2023	Jul 31, 2023	—	$3.44	$3.40	-1.16%
— Q2 FY2023	Apr 30, 2023	—	$2.00	$1.70	-15.00%
— Q1 FY2023	Jan 31, 2023	—	$3.60	$3.30	-8.33%

Q3 FY2023-1.16%

Report Date

Jul 31, 2023

EPS Beat/Miss

—

Price Before

$3.44

Price After

$3.40

Q2 FY2023-15.00%

Report Date

Apr 30, 2023

EPS Beat/Miss

—

Price Before

$2.00

Price After

$1.70

Q1 FY2023-8.33%

Report Date

Jan 31, 2023

EPS Beat/Miss

—

Price Before

$3.60

Price After

$3.30

Beat Rate0 / 3 quarters

Largest Move-15.00% (Q2 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Organicell Regenerative Medicine, Inc. (OCEL) most recently reported earnings on July 31, 2023 for Q3 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next OCEL earnings date is expected around September 1, 2026.

Each quarter, investors track OCEL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OCEL revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

OCEL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

OCEL earnings · 4 questions

Organicell Regenerative Medicine, Inc.'s next earnings report is expected around September 1, 2026. OCEL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OCEL historically reports after market close (AMC).

OCEL earnings datewhen is OCEL earningsOCEL next earnings datewhen does OCEL report earningsOCEL earnings calendar

▸ Source: FMP · Organicell Regenerative Medicine, Inc. SEC filings · US GAAP · Organicell Regenerative Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026